We are live on ! Find out more
TSVT

2seventy bio
TSVT

Delisted

TSVT was delisted on the 13th of May, 2025.

Back to rankings

2 hedge funds and large institutions have $508K invested in 2seventy bio in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 139 → 2 (-137)

100% less capital invested

Capital invested by funds: $234M → $508K (-$234M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 137

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
2
Holders Change
-137
Holders Change %
-98.56%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
137
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$23.1M
2
BCM
Beryl Capital Management
California
-$21M
3
BlackRock
BlackRock
New York
-$19.6M
4
Morgan Stanley
Morgan Stanley
New York
-$14.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$13.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
– -$2.01M -406,055 Closed
Northern Trust
27
Northern Trust
Illinois
– -$1.97M -398,910 Closed
GLAM
28
Gardner Lewis Asset Management
Pennsylvania
– -$1.96M -395,936 Closed
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
– -$1.95M -394,013 Closed
DIG
30
DeepCurrents Investment Group
New York
– -$1.93M -390,169 Closed
Deutsche Bank
31
Deutsche Bank
Germany
– -$1.84M -371,630 Closed
OAM
32
Oxford Asset Management
United Kingdom
– -$1.74M -352,739 Closed
CIEC
33
Crédit Industriel et Commercial
France
– -$1.58M -320,000 Closed
MCM
34
Monimus Capital Management
New Jersey
– -$1.46M -296,260 Closed
GF
35
Gabelli Funds
New York
– -$1.25M -252,500 Closed
UBS Group
36
UBS Group
Switzerland
– -$1.2M -243,434 Closed
Invesco
37
Invesco
Georgia
– -$1.06M -215,494 Closed
Millennium Management
38
Millennium Management
New York
– -$1.05M -212,298 Closed
AA
39
ABC Arbitrage
France
– -$992K -200,792 Closed
GCIA
40
Gabelli & Co Investment Advisers
New York
– -$951K -192,450 Closed
BCM
41
BCK Capital Management
Connecticut
– -$944K -191,000 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$889K -180,057 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$747K -151,136 Closed
Wellington Management Group
44
Wellington Management Group
Massachusetts
– -$729K -147,663 Closed
SC
45
Sagefield Capital
Texas
– -$572K -115,889 Closed
OBAM
46
ODDO BHF Asset Management
France
– -$546K -110,608 Closed
WIC
47
Water Island Capital
New York
– -$514K -104,006 Closed
Mirae Asset Global ETFs Holdings
48
Mirae Asset Global ETFs Holdings
Hong Kong
– -$506K -102,512 Closed
American Century Companies
49
American Century Companies
Missouri
– -$466K -94,272 Closed
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
– -$419K -84,817 Closed
1
2
3 4 5

TSVT Hedge Fund Activity: Q2 2025 in Review

2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2025, worth a combined $508K — down 100% from $234M a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of TSVT and 0 opened new positions — a net loss of 137 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Goldman Sachs, exiting entirely with an estimated $23.1M sold.

  • 2 institutional investors held 2seventy bio (TSVT) as of Q2 2025, down from 139 in Q1 2025.
  • Funds reported $508K of 2seventy bio stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new 2seventy bio positions in Q2 2025 and 137 closed out, a net change of -137 holders.
  • The largest 2seventy bio seller in Q2 2025 was Goldman Sachs, an estimated $23.1M sold.

Based on aggregated 13F filings for Q2 2025.